Idifarma has participated, together with other leading CDMOs, in an article for the journal Pharmaceutical Technology, focusing in Spray Drying as the most suitable best solution for solubility issues in the development process of a pharmaceutical product.
“Solubility, bioavailability and stability are some of the biggest challenges facing the pharmaceutical industry today,” said Manuel Leal, Business Development Director of Idifarma.
This technology consists of a process in which by spraying a solution or suspension that contains the excipient and active ingredients, an amorphous solid dispersion (ASD) with a different particle size is obtained. The ASDs obtained after spray drying achieve better solubility than the API alone.
Idifarma, in line with its growth and innovation strategy, has been working with this technology for several years, offering a GMP manufacturing service with Spray Dryer for high potency products (up to category 4 OEL/OEB).
Read the full article here.